Abelacimab Demonstrates Potential of Factor XI Inhibition in Preventing Blood Clots

July 19, 2021

A 412-patient trial comparing 3 dosing regimens of abelacimab versus enoxaparin, results indicate all 3 regimens of abelacimab demonstrated noninferiority against enoxaparin and 2 of the 3 demonstrated superiority against the current standard of care.

Preventing Stroke: Management of Patients Undergoing Noncardiac and Nonneurological Surgery

April 22, 2021

Dr. Gregory Weiss, a cardiovascular anesthesiologist, breaks down and provides real-world perspective on the application of a recent scientific statement from the AHA and ASA on perioperative management to lower stroke risk in patients undergoing noncardiac and nonneurological procedures.

DOACs May be More Effective than Warfarin for Valvular AFib

March 30, 2021

An analysis of claims data by investigators at University of Pennsylvania indicates DOACs were associated with a 36% lower risk of stroke or systemic embolism and was also associated with a reduction in risk of major bleeding.